go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Delaware rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $575,440 · 10th to 90th $575,440 to $575,440Professionalmedian $575,440 · 10th to 90th $575,440 to $588,844
facility $575,440professional $575,440

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$575,439.94
Median
$575,439.94
Typical High
$575,439.94
Aetna
Setting
Professional
Modifier
None
Typical Low
$575,439.94
Median
$575,439.94
Typical High
$575,439.94
Aetna
Setting
Professional
Modifier
52 · Reduced service
Typical Low
$288,403.15
Median
$288,403.15
Typical High
$288,403.15
Aetna
Setting
Professional
Modifier
53 · Discontinued
Typical Low
$114,815.36
Median
$114,815.36
Typical High
$114,815.36
Aetna
Setting
Professional
Modifier
55 · Aftercare only
Typical Low
$87,096.36
Median
$87,096.36
Typical High
$87,096.36
Aetna
Setting
Professional
Modifier
56 · Pre-op care only
Typical Low
$57,543.99
Median
$57,543.99
Typical High
$57,543.99
United
Setting
Professional
Modifier
None
Typical Low
$512,861.38
Median
$851,138.04
Typical High
$851,138.04